Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back
Session Evaluation

CaNET

120 - TRANSLATION FROM RESEARCH TO PRACTICE

Thursday, October 24, 2024
9:45 AM – 12:00 PM PT
Room: 111-112
The Cardiovascular Network of Canada (CANet) is a multidisciplinary and multi-sectoral network focused on patient-led cardiac research discovery, innovation, and engagement.

In this session, our presenters will describe the translation of their innovative research and discoveries into practice - specifically, in the management of patients with cardiovascular diseases such as atrial fibrillation, syncope, ventricular tachycardiac, and sudden cardiac death.

Presenters will also explore key advancements in cardiovascular research using digital health and artificial intelligence with a focus on a personalized approach to improving cardiovascular health outcomes.

The session will be chaired by Dr. Ratika Parkash, CANet Associate Scientific Director and Dr. Brent Mitchell, CANet Investigator.

Evolution of a National Network of Excellence - Anthony Tang
Advances in the Management of Patients with Atrial Fibrillation - Jason Andrade
Magic Drug for Syncope - Robert Sheldon
Management of Patients with Ventricular Tachycardia - John Sapp
Evolution of Clinical Research Methodology - George Wells
Prevention of Sudden Cardiac Death After Myocardial Infarction - Derek Exner
Personalized Approach to Improving Cardiovascular Health - Anthony Tang & Ratika Parkash
Application of Artificial Intelligence to Improve Cardiovascular Health - Pavel Antiperovitch

Learning Objectives:

At the end of this session participants will be able to:
  • Identify key advancements in the management of patients with cardiovascular diseases such as atrial fibrillation, syncope, ventricular tachycardiac, and sudden cardiac death;
  • Order the evolution of clinical research methodology;
  • Describe a personalized approach to improving cardiovascular health; and
  • Recognize how artificial intelligence can improve cardiovascular health.
Disclosure(s):
Ratika Parkash: Abbott: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)
L. Brent Mitchell, MD: Medtronic Inc: Consultant/Advisory Board (Ongoing)
Jason G. Andrade, MD: No financial relationships to disclose
Robert S. Sheldon, MD PhD FRCP(C) FCAHS FCCS: No financial relationships to disclose
John L. Sapp, MD, Jr.: Abbott: Investigator Initiated Research Grant (Ongoing), Speaker Honoraria (Ongoing); Johnson and Johnson: Investigator Initiated Research Grant (Ongoing), Speaker Honoraria/Consulting (Ongoing); Medtronic: Speaker honoraria (Ongoing); Varian: Research consulting (Ongoing)
Anthony Tang: No financial relationships to disclose